Overview

Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch

Status:
Completed
Trial end date:
2012-04-25
Target enrollment:
Participant gender:
Summary
The Summary of product characteristics (SmPC) for QUTENZA advises that topical anaesthetic is applied prior to the application of QUTENZA. This is a multi-center, randomized, assessor-blinded study which will investigate the use of an oral analgesic as an alternative form of pre-treatment for QUTENZA.
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Capsaicin
Lidocaine
Tramadol